Postprandial Plasma Glucose With a Fasting Time of 4–7.9 h Is Positively Associated With Cancer Mortality in US Adults
Diabetes/Metabolism Research and Reviews · 2024
DOI: 10.1002/dmrr.70008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, 2024. Verfasst von Yutang Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Life Science, Institute of Innovation, Science and Sustainability, Federation University Australia, Ballarat, Australia. Hauptthemen laut MEDLINE: Neoplasms, Fasting, Blood Glucose, Postprandial Period. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Health and Medical Research Council of Australia.
Abstract (Originalsprache)
Aims
This study investigated the association of postprandial plasma glucose (PPG) with cancer mortality using a general cohort of US adults. Materials and Methods This cohort study included 14,860 US adults who attended the third National Health and Nutrition Examination Survey from 1988 to 1994, with mortality being followed up until December 31, 2019. The explanatory variable was the level of plasma glucose, including PPG with a fasting time of 0–3.9 h (PPG 0–3.9h ) and 4–7.9 h (PPG 4–7.9h ), plasma glucose with a fasting time ≥8 h (PG fasting ), and plasma glucose at 2 h after oral glucose tolerance test (PG 2hOGTT ). Plasma glucose‐associated cancer mortality risk was assessed using Cox proportional hazard models.
Results
A 1‐natural‐log‐unit increase in PPG 4–7.9h was associated with a higher multivariate‐adjusted risk for cancer mortality [hazard ratio (HR), 3.24; 95% confidence interval (CI), 1.50–7.00]. However, PPG 0–3.9h , PG fasting , PG 2hOGTT , haemoglobin A 1c , and insulin were not significantly associated with cancer mortality. The positive association of PPG 4–7.9h with cancer mortality remained in those without a prior diagnosis of cancer.
Conclusions
High PPG 4–7.9h is associated with a higher cancer mortality risk in US adults. Lowering PPG 4–7.9h may reduce cancer mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Life Science, Institute of Innovation, Science and Sustainability, Federation University Australia, Ballarat, Australia.
- Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München (LMU), Munich, Germany.
- Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Townsville, Australia.
- Department of Vascular and Endovascular Surgery, The Townsville University Hospital, Townsville, Australia.
- Department of Epidemiology and Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- RCCS MultiMedica, Milan, Italy.
ORCID-Profile: Yutang Wang, Jonathan Golledge, Antonio Ceriello
Förderung
- National Health and Medical Research Council of Australia
Zitieren
APA
Wang, Y., Fang, Y., Habenicht, A. J. R., Golledge, J., Giovannucci, E. L., & Ceriello, A. (2024). Postprandial Plasma Glucose With a Fasting Time of 4–7.9 h Is Positively Associated With Cancer Mortality in US Adults. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.70008
Vancouver
Wang Y, Fang Y, Habenicht AJR, Golledge J, Giovannucci EL, Ceriello A. Postprandial Plasma Glucose With a Fasting Time of 4–7.9 h Is Positively Associated With Cancer Mortality in US Adults. Diabetes/Metabolism Research and Reviews. 2024. doi:10.1002/dmrr.70008
BibTeX
@article{Wang2024,
author = {Wang, Yutang and Fang, Yan and Habenicht, Andreas J R and Golledge, Jonathan and Giovannucci, Edward L and Ceriello, Antonio},
title = {Postprandial Plasma Glucose With a Fasting Time of 4–7.9 h Is Positively Associated With Cancer Mortality in US Adults},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2024},
doi = {10.1002/dmrr.70008}
}
EUVIMED